TLRY

Tilray Brands, Inc. Common Stock

Basic Materials · Medicinal Chemicals & Botanical Products
$5.53-2.15% today
AI Take · AlgoThesis

Tilray's microscopic $0.7B market cap masks a company burning through credibility—it's unprofitable (hence the missing P/E), trading nowhere near its 52-week high despite a relatively neutral RSI of 43.2. With 14.16% short interest representing meaningful skepticism and the cannabis sector still facing regulatory headwinds, the stock sits in a fragile position: too small to command institutional confidence, too leveraged to macro sentiment to offer safety. The lack of earnings power combined with below-peak pricing suggests the market has already priced in significant distress, making any bounce vulnerable to reality checks rather than sustainable momentum.

Snapshot

Market cap
$675.8M
P/E
Forward P/E
EPS (TTM)
$-1.95
Dividend yield
Net margin
-156.7%
ROE
-86.9%
RSI (14)
43
Beta
2.16
Short % of float
14.2%
Days to cover
2.3
52w high
No

Recent headlines

Peers in Medicinal Chemicals & Botanical Products

Build a thesis around TLRY

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →